China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2021)
Historic Long-Term Deferred Tax for China SXT Pharmaceuticals (SXTC) over the last 4 years, with Q1 2021 value amounting to $321444.0.
- China SXT Pharmaceuticals' Long-Term Deferred Tax rose 18486.96% to $321444.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $321444.0, marking a year-over-year increase of 18486.96%. This contributed to the annual value of $321444.0 for FY2021, which is 18486.96% up from last year.
- As of Q1 2021, China SXT Pharmaceuticals' Long-Term Deferred Tax stood at $321444.0, which was up 18486.96% from $23367.0 recorded in Q3 2020.
- In the past 5 years, China SXT Pharmaceuticals' Long-Term Deferred Tax ranged from a high of $321444.0 in Q1 2021 and a low of $6174.0 during Q1 2018
- Over the past 4 years, China SXT Pharmaceuticals' median Long-Term Deferred Tax value was $18435.5 (recorded in 2019), while the average stood at $81667.8.
- The largest annual percentage gain for China SXT Pharmaceuticals' Long-Term Deferred Tax in the last 5 years was 73559.69% (2020), contrasted with its biggest fall of 8429.69% (2020).
- Quarter analysis of 4 years shows China SXT Pharmaceuticals' Long-Term Deferred Tax stood at $6174.0 in 2018, then surged by 105.36% to $12679.0 in 2019, then surged by 84.3% to $23367.0 in 2020, then soared by 1275.63% to $321444.0 in 2021.
- Its Long-Term Deferred Tax was $321444.0 in Q1 2021, compared to $23367.0 in Q3 2020 and $112839.0 in Q1 2020.